Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Cited by (999)

Items 301–400 of 999

  1. Alpha-synuclein activates BV2 microglia dependent on its aggregation state
    Alana Hoffmann, Benjamin Ettle, Ariane Bruno, Anna O. Kulinich, Anna-Carin Hoffmann, Julia von Wittgenstein, Jürgen Winkler, Wei Xiang, Johannes C. M. Schlachetzki · 2016 · Biochemical and Biophysical Research Communications
  2. Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine
    Fabio Blandini, Roberto Cilia, Silvia Cerri, Gianni Pezzoli, Anthony H.V. Schapira, Stephen Mullin, José Luis Lanciego · 2018 · Movement Disorders
  3. Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
    Noha A. Gouda, Ahmed Elkamhawy, Jungsook Cho · 2022 · Biomedicines
  4. Controlling the mass action of α‐synuclein in Parkinson’s disease
    Changyoun Kim, Seung‐Jae Lee · 2008 · Journal of Neurochemistry
  5. Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats
    Zhongwang Yu, Xiaohui Xu, Zhenghua Xiang, Jianfeng Zhou, Zhaohuan Zhang, Chun Hu, Cheng He · 2010 · PLoS ONE
  6. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
    Richard Gordon, Neeraj Singh, Vivek Lawana, Anamitra Ghosh, Dilshan S. Harischandra, Huajun Jin, Colleen Hogan, Souvarish Sarkar, Dharmin Rokad, Nikhil Panicker et al. · 2016 · Neurobiology of Disease
  7. Microglia-targeting nanotherapeutics for neurodegenerative diseases
    Zhao, Nanxia, Francis, Nicola L., Calvelli, Hannah R., Moghe, Prabhas V. · 2020 · APL Bioengineering
  8. α-Synuclein pathology as a target in neurodegenerative diseases
    Hye-Jin Park, Tae‐In Kam, Valina Lynn Dawson, Ted M. Dawson · 2024 · Nature Reviews Neurology
  9. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype
    Kate Roberts, Rafaa Zeineddine, Lisa Corcoran, Wen Li, Iain Leslie Campbell, Justin J. Yerbury · 2012 · Glia
  10. NADPH oxidases: redox regulation of cell homeostasis and disease
    Damir Kračun, Lucia Rossetti Lopes, Eugenia Cifuentes-Pagano, Patrick J. Pagano · 2025 · Physiological Reviews
  11. A simple magnetic separation method for high-yield isolation of pure primary microglia
    Richard Gordon, Colleen Hogan, Matthew P Neal, Vellareddy Anantharam, Anumantha G. Kanthasamy, Arthi Kanthasamy · 2010 · Journal of Neuroscience Methods
  12. DJ‐1 deficiency impairs autophagy and reduces alpha‐synuclein phagocytosis by microglia
    Nash, Yuval, Schmukler, Eran, Trudler, Dorit, Pinkas‐Kramarski, Ronit, Frenkel, Dan · 2017 · Journal of Neurochemistry
  13. Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
    Yumin Wang, Luyan Gao, Jichao Chen, Qiang Li, Liang Huo, Yanchao Wang, Hongquan Wang, Jichen Du · 2021 · Frontiers in Pharmacology
  14. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
    Yao Xiang, Xiaohua Song, Dingxin Long · 2024 · Archives of Toxicology
  15. Head Injury, Alpha-Synuclein Rep1 and Parkinson’s Disease
    S. Goldman, F. Kamel, G. Ross, S. Jewell, Grace S. Bhudhikanok, D. Umbach, C. Marras, R. Hauser, J. Jankovic, S. Factor et al. · 2012 · Annals of Neurology
  16. TREM2 deficiency aggravates α‐synuclein–induced neurodegeneration and neuroinflammation in Parkinson's disease models
    Guo, Ying, Wei, Xinbing, Yan, Hua, Qin, Yue, Yan, Shaoqi, Liu, Jia, Zhao, Yong, Jiang, Fan, Lou, Haiyan · 2019 · The FASEB Journal
  17. Role of Prostaglandins in Neuroinflammatory and Neurodegenerative Diseases
    Isabel Vieira de Assis Lima, Leandro Francisco Silva Bastos, Marcelo Limborço‐Filho, Bernd L. Fiebich, Antônio Carlos Pinheiro de Oliveira · 2012 · Mediators of Inflammation
  18. Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
    Naomi P. Visanji, Anthony Edward Lang, Gábor Géza Kovács · 2019 · Translational Neurodegeneration
  19. Increased Amoeboid Microglial Density in the Olfactory Bulb of P arkinson's and A lzheimer's Patients
    Karlijn J. Doorn, Andrea Goudriaan, Carla T. Blits‐Huizinga, John G. J. M. Bol, Annemieke J.M. Rozemüller, Piet V.J.M. Hoogland, Paul John Lucassen, Benjamin Drukarch, Wilma D. J. van de Berg, Anne‐Marie van Dam · 2013 · Brain Pathology
  20. Parkinson disease with REM sleep behavior disorder
    Yang Hu, Shuyang Yu, Li-Jun Zuo, Chen-Jie Cao, Fang Wang, Ze-Jie Chen, Yang Du, Tenghong Lian, Yajie Wang, Piu Chan et al. · 2015 · Neurology
  21. Role of microglial redox balance in modulation of neuroinflammation
    Nadia Giselle Innamorato, Isabel Lastres‐Becker, Antonio Cuadrado · 2009 · Current Opinion in Neurology
  22. Wnt3a induces exosome secretion from primary cultured rat microglia
    Claudie Hooper, Ricardo Sáinz‐Fuertes, Steven Lynham, Abdul Hye, Richard Killick, Alice Warley, Cecilia Bolondi, Jennifer M. Pocock, Simon Lovestone · 2012 · BMC Neuroscience
  23. Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease
    Karlijn J. Doorn, Paul John Lucassen, H. W. G. M. Boddeke, Marloes Prins, Henk W. Berendse, Benjamin Drukarch, Anne‐Marie van Dam · 2012 · Progress in Neurobiology
  24. The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
    Anna Zinger, Carlos Barcia, María Trinidad Herrero, Gilles J. Guillemin · 2011 · Parkinson s Disease
  25. Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants
    Cintia Roodveldt, Adahir Labrador‐Garrido, Elena González‐Rey, Rafael Fernández-Montesinos, Marta Caro, Christian Claude Lachaud, Christopher A. Waudby, Mario Delgado, Christopher Martin Dobson, David Pozo · 2010 · PLoS ONE
  26. Cytotoxicity of paraquat in microglial cells: Involvement of PKCδ- and ERK1/2-dependent NADPH oxidase
    Rebecca L. Miller, Grace Y. Sun, Albert Y. Sun · 2007 · Brain Research
  27. Correction to: Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
    Craig D. Hughes, Minee L. Choi, Mina Ryten, Lee Hopkins, Anna Drews, Juan Antonio Botía, Maria Iljina, Margarida Rodrigues, Sarah A. Gagliano Taliun, Sonia Gandhi et al. · 2018 · Acta Neuropathologica
  28. Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway
    Hou, Liyan, Bao, Xiuqi, Zang, Caixia, Yang, Hanyu, Sun, Fuqiang, Che, Yuning, Wu, Xuefei, Li, Shao, Zhang, Dan, Wang, Qingshan · 2018 · Redox Biology
  29. The microbiota–microglia axis in central nervous system disorders
    Mossad, Omar, Erny, Daniel · 2020 · Brain Pathology
  30. Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation
    Cintia Roodveldt, Adahir Labrador‐Garrido, Elena González‐Rey, Christian Claude Lachaud, Tim Guilliams, Rafael Fernández-Montesinos, Alicia Benitez-Rondan, Gema Robledo, Abdelkrim Hmadcha, Mario Delgado et al. · 2013 · PLoS ONE
  31. Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease
    Karamjeet Kaur, Jaskamal Singh Gill, Puneet Kumar Bansal, Rahul R Deshmukh · 2017 · Journal of the Neurological Sciences
  32. The cannabinoid system and microglia in health and disease
    Samuel S. Duffy, Jessica P. Hayes, Nathan T. Fiore, Gila Moalem‐Taylor · 2021 · Neuropharmacology
  33. Inflammation in transgenic mouse models of neurodegenerative disorders
    Schwab, Claudia, Klegeris, Andis, McGeer, Patrick. L. · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  34. Neuroinflammation in Lewy body dementia
    Ajenthan Surendranathan, James Benedict Rowe, John Tiernan O'Brien · 2015 · Parkinsonism & Related Disorders
  35. The Role of Anti-Inflammatory Agents in Parkinson???s Disease
    McGeer, Edith G, McGeer, Patrick L · 2007 · CNS Drugs
  36. Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK
    Duy-Khanh Dang, Eun‐Joo Shin, Yunsung Nam, Sungwoo Ryoo, Ji Hoon Jeong, Choon‐Gon Jang, Toshitaka Nabeshima, Jau‐Shyong Hong, Hyoung‐Chun Kim · 2016 · Journal of Neuroinflammation
  37. TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons
    Maatouk, Layal, Compagnion, Anne-Claire, Sauvage, Maria-Angeles Carrillo-de, Bemelmans, Alexis-Pierre, Leclere-Turbant, Sabrina, Cirotteau, Vincent, Tohme, Mira, Beke, Allen, Trichet, Michaël, Bazin, Virginie et al. · 2018 · Nature Communications
  38. Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit
    Gesine Paul, Osama F. Elabi · 2022 · Frontiers in Aging Neuroscience
  39. Immunological features of α‐synuclein in Parkinson's disease
    Cintia Roodveldt, John Christodoulou, Christopher Martin Dobson · 2008 · Journal of Cellular and Molecular Medicine
  40. Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
    Souvarish Sarkar, Eric B. Dammer, Emir Malovic, Abby L. Olsen, Syed Ali Raza, Tianwen Gao, Hailian Xiao, Danielle L. Oliver, Duc Minh Duong, Valerie L. Joers et al. · 2020 · Frontiers in Immunology
  41. Potent regulation of microglia‐derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin
    Michelle L. Block, G. Li, Liya Qin, Xin Wu, Zhong Pei, T. Wang, Belinda C. Wilson, Jun Ho Yang, Jau‐Shyong Hong · 2006 · The FASEB Journal
  42. Oligomeric α-synuclein inhibits tubulin polymerization
    Leo Chen, Jinghua Jin, Jeanne Davis, Yong Feng Zhou, Yan Wang, Jun Liu, Paul J. Lockhart, Jing Zhang · 2007 · Biochemical and Biophysical Research Communications
  43. Import and Export of Misfolded α-Synuclein
    Rodriguez, Lilia, Marano, Maria M., Tandon, Anurag · 2018 · Frontiers in Neuroscience
  44. Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation
    Vieira, Bruno Di Marco, Radford, Rowan A., Chung, Roger S., Guillemin, Gilles J., Pountney, Dean L. · 2015 · Frontiers in Cellular Neuroscience
  45. Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study
    Heather Wilson, George Dervenoulas, Gennaro Pagano, Robin J. Tyacke, Sotirios Polychronis, Jim Myers, Roger N. Gunn, Eugenii A. Rabiner, David Nutt, Marios Politis · 2019 · Brain
  46. Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson’s disease
    Dawn C. Duke, Linda B Moran, Michail E. Kalaitzakis, Manuel Deprez, David Trevor Dexter, R. K. B. Pearce, Manuel B. Graeber · 2006 · Neurogenetics
  47. Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases
    Mehdi Ghasemi, Ali S. Fatemi · 2014 · Neuroscience & Biobehavioral Reviews
  48. Type‐1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease
    Main, Bevan S., Zhang, Moses, Brody, Kate M., Ayton, Scott, Frugier, Tony, Steer, David, Finkelstein, David, Crack, Peter J., Taylor, Juliet M. · 2016 · Glia
  49. NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases
    Annamaria Lanzillotta, Vanessa Porrini, Arianna Bellucci, Marina Benarese, Caterina Branca, Edoardo Parrella, PierFranco Spano, Marina Pizzi · 2015 · Frontiers in Neurology
  50. Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration
    Wei Zhang, Zhaofen Yan, Junhua Gao, Li Sun, Xiyan Huang, Zhuo Liu, Shuyang Yu, Chen-Jie Cao, Li-jun Zuo, Zejie Chen et al. · 2013 · Molecular Neurobiology
  51. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis
    Yu Ree Choi, Seo‐Jun Kang, Jin-Mo Kim, Seung‐Jae Lee, Ilo Jou, Eun-hye Joe, Sang Myun Park · 2015 · Neurobiology of Disease
  52. Microglial cells and Parkinson’s disease
    Qian Li, Patrick M. Flood · 2008 · Immunologic Research
  53. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
    Ana Isabel Rodriguez-Perez, Diego Sucunza, María A. Pedrosa, Pablo Garrido‐Gil, Jaime Kulisevsky, José Luis Lanciego, José Luis Labandeira-García · 2018 · Neurotherapeutics
  54. The Plasma Membrane: A Platform for Intra- and Intercellular Redox Signaling
    Nordzieke, Daniela E., Medraño-Fernandez, Iria · 2018 · Antioxidants
  55. A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease
    Pabon, Mibel M., Jernberg, Jennifer N., Morganti, Josh, Contreras, Jessika, Hudson, Charles E., Klein, Ronald L., Bickford, Paula C. · 2012 · PLoS ONE
  56. The role of natural killer cells in Parkinson’s disease
    Rachael H. Earls, Jae‐Kyung Lee · 2020 · Experimental & Molecular Medicine
  57. Anti‐inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide‐stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase‐1 expression
    Jisun Jung, Jin Ah Shin, Eun‐Mi Park, Jungeun Lee, Young‐Sook Kang, Sung‐Won Min, Dong‐Hyun Kim, Jin Won Hyun, Chan‐Young Shin, Hee‐Sun Kim · 2010 · Journal of Neurochemistry
  58. Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
    Sara Castro‐Sánchez, Ángel J. García‐Yagüe, Tresa López‐Royo, Marı́a José Casarejos, José Luis Lanciego, Isabel Lastres‐Becker · 2018 · Glia
  59. Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin From the Substantia Nigra in Parkinson Disease
    Candan Depboylu, Martin K.-H. Schafer, Óscar Arias-Carrión, Wolfgang Hermann Oertel, Eberhard Weihe, Günter U. Höglinger · 2011 · Journal of Neuropathology & Experimental Neurology
  60. Inhibition of Neuroinflammation and Mitochondrial Dysfunctions by Carbenoxolone in the Rotenone Model of Parkinson’s Disease
    Poonam Singh Thakur, Bimla Nehru · 2014 · Molecular Neurobiology
  61. Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death
    Liuke Sun, Ruifang Shen, Sandeep Kumar Agnihotri, Yun Chen, Zhiwei Huang, Hansruedi Büeler · 2018 · Scientific Reports
  62. Exercise and Neuroinflammation in Health and Disease
    Seo, Dae-Yun, Heo, Jun-Won, Ko, Jeong Rim, Kwak, Hyo-Bum · 2019 · International Neurourology Journal
  63. Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators
    J. Saravanan, Praveen Thaggikuppe Krishnamurthy · 2021 · Neurochemistry International
  64. Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria
    S. Schmidt, Bettina Linnartz‐Gerlach, Sonja Mendritzki, Teresa Sczepan, Michael Lübbert, Christine C. Stichel, Hermann Lübbert · 2011 · Human Molecular Genetics
  65. A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors
    Jacob A. Sloane, Daina Blitz, Zachary R. Margolin, Timothy K. Vartanian · 2009 · NeuroMolecular Medicine
  66. Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
    Sonia George, Patrik Brundin · 2015 · Journal of Parkinson s Disease
  67. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
    Elodie Kip, Louise C. Parr‐Brownlie · 2022 · Ageing Research Reviews
  68. Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration
    Ngan Pan Bennett Au, Chi Him Eddie Ma · 2017 · Frontiers in Aging Neuroscience
  69. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
    Melek Firat Altay, Alan King Lun Liu, Janice L. Holton, Laura Parkkinen, Hilal Ahmed Lashuel · 2022 · Acta Neuropathologica Communications
  70. Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
    Shuanglong Yi, Linfang Wang, Honglei Wang, Margaret Su-chun Ho, Shiping Zhang · 2022 · International Journal of Molecular Sciences
  71. Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease
    Shuwen Cao, Shaji Theodore, David G. Standaert · 2010 · Molecular Neurodegeneration
  72. Common Inflammatory Mechanisms in Lewy Body Disease and Alzheimer Disease
    Robert Emil Mrak, W. Sue T. Griffin · 2007 · Journal of Neuropathology & Experimental Neurology
  73. Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
    Amanda N. Sacino, Mieu Brooks, Nicholas H. McGarvey, Alex B. McKinney, Michael A Thomas, Yona Levites, Yong Ran, Todd Eliot Golde, Benoit I. Giasson · 2013 · Acta Neuropathologica Communications
  74. Neurodegenerative diseases: The immunological perspective
    Monica Molteni, Carlo Rossetti · 2017 · Journal of Neuroimmunology
  75. Identification of Glutathione S-Transferase Pi as a Protein Involved in Parkinson Disease Progression
    Min Yan Shi, Joshua M. Bradner, Theo K. Bammler, David L. Eaton, Jianpeng Zhang, Zu‐Cheng Ye, Angela M. Wilson, Thomas Jude Montine, Catherine Pan, Jing Zhang · 2009 · American Journal Of Pathology
  76. Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy
    Ana Raquel Santiago, Raquel Boia, Inês Dinis Aires, António Francisco Ambrósio, Rosa Fernandes · 2018 · Frontiers in Physiology
  77. Senescent Microglia: The Key to the Ageing Brain?
    Greenwood, Eleanor K., Brown, David R. · 2021 · International Journal of Molecular Sciences
  78. Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain
    Francesca L’Episcopo, Cataldo Tirolo, Maria Francesca Serapide, Salvatore Caniglia, Nunzio Testa, Loredana Leggio, Silvia Vivarelli, Nunzio Iraci, Stefano Pluchino, Bianca Marchetti · 2018 · Frontiers in Aging Neuroscience
  79. Human mini-brain models
    Hsih Yin Tan, Hansang Cho, Luke P. Lee · 2020 · Nature Biomedical Engineering
  80. Interaction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia
    Houfang Long, Shengnan Zhang, Shuyi Zeng, Yilun Tong, Jun Liu, Cong Liu, Dan Li · 2022 · Cell Reports
  81. Late-onset Parkinsonism in NF B/c-Rel-deficient mice
    Chiara Baiguera, Manuela Alghisi, Annalisa Pinna, Arianna Bellucci, Maria Antonietta De Luca, Lucia Frau, Micaela Morelli, Rosaria Ingrassia, Marina Benarese, Vanessa Porrini et al. · 2012 · Brain
  82. Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy
    Hoffmann, Alana, Ettle, Benjamin, Battis, Kristina, Reiprich, Simone, Schlachetzki, Johannes C. M., Masliah, Eliezer, Wegner, Michael, Kuhlmann, Tanja, Riemenschneider, Markus J., Winkler, Jürgen · 2019 · Brain Pathology
  83. Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions
    James A. Varley, David James Brooks, Paul Edison · 2014 · Alzheimer s & Dementia
  84. Molecular Insights into Parkinson's Disease
    Jean‐Christophe Rochet, Bruce A. Hay, Ming Guo · 2012 · Progress in molecular biology and translational science
  85. Pathologic Modifications of α-Synuclein in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Treated Squirrel Monkeys
    Alison L. McCormack, Sally K. Mak, Maryam Shenasa, J. William Langston, Lysia S. Forno, Donato A. Di Monte · 2008 · Journal of Neuropathology & Experimental Neurology
  86. Suppression of Map Kinases Inhibits Microglial Activation and Attenuates Neuronal Cell Death Induced by α-Synuclein Protofibrils
    Henrik Wilms, Philip C Rosenstiel, Marina Romero‐Ramos, Alexander Arlt, H. Schäfer, Dirk Seegert, Philipp J. Kahle, Sabine Odoy, Jan-Hendrik Claasen, Christian Holzknecht et al. · 2009 · International Journal of Immunopathology and Pharmacology
  87. NEW evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease
    Sun Shan, Tang Hong-Min, Feng Yi, Gao Jun-Peng, F. -L. Yue, Tang Yan-hong, Yang Yun-ke, Wenwei Li, Xiangyu Wang, Jun Ma et al. · 2009 · Neurobiology of Aging
  88. Proteomic Studies of Nitrated Alpha-Synuclein Microglia Regulation by CD4+CD25+ T Cells
    Ashley D. Reynolds, David K. Stone, Rodney Lee Mosley, Howard Eliot Gendelman · 2009 · Journal of Proteome Research
  89. Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease
    Beatrice Macchi, Rosanna Di Paola, Francesca Marino‐Merlo, Maria Rosa Felice, Salvatore Cuzzocrea, Antonio Mastino · 2015 · CNS & Neurological Disorders - Drug Targets
  90. γ-Synuclein: Seeding of α-Synuclein Aggregation and Transmission between Cells
    Irina G. Surgucheva, Victor S. Sharov, Andrei P. Surguchov · 2012 · Biochemistry
  91. The Contribution of α -Synuclein Spreading to Parkinson’s Disease Synaptopathy
    Francesca Longhena, Gaia Faustini, Cristina Missale, Marina Pizzi, PierFranco Spano, Arianna Bellucci · 2017 · Neural Plasticity
  92. Studying neurodegenerative diseases in culture models
    Johannes C. M. Schlachetzki, Soraya Wilke Saliba, Antônio Carlos Pinheiro de Oliveira · 2013 · Brazilian Journal of Psychiatry
  93. Complex Deregulation and Expression of Cytokines and Mediators of the Immune Response in P arkinson's Disease Brain is Region Dependent
    Paula Garcia‐Esparcia, Franc Llorens, Margarita Carmona, Isidró Ferrer · 2014 · Brain Pathology
  94. Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease
    Francesca L’Episcopo, Cataldo Tirolo, Salvatore Caniglia, Nunzio Testa, Maria C. Morale, Maria Francesca Serapide, Stefano Pluchino, Bianca Marchetti · 2014 · Journal of Molecular Cell Biology
  95. Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
    Louisa C. Johnston, Xiaomin Su, Kathleen A. Maguire‐Zeiss, Karen Horovitz, Irina Ankoudinova, Dmitry Y. Guschin, Piotr Hadaczek, Howard J. Federoff, Krystof S. Bankiewicz, John Forsayeth · 2008 · Molecular Therapy
  96. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Marco Bisaglia, Roberta Filograna, Mariano Beltramini, Luigi Bubacco · 2014 · Ageing Research Reviews
  97. Microglial Activation Induced by Neurodegeneration
    Yong Feng Zhou, Yan Wang, Monika Kovacs, Jinghua Jin, Jing Zhang · 2005 · Molecular & Cellular Proteomics
  98. The role of α-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response
    Mikhail Y. Golovko, Gwendolyn Barceló‐Coblijn, Paula I. Castagnet, Susan A. Austin, Colin Kelly Combs, Eric J. Murphy · 2008 · Molecular and Cellular Biochemistry
  99. Antidepressants reduce neuroinflammatory responses and astroglial alpha‐synuclein accumulation in a transgenic mouse model of multiple system atrophy
    Elvira Valera, Kiren K. Ubhi, Michael Mante, Edward M. Rockenstein, Eliezer Masliah · 2013 · Glia
  100. Differential regional expression patterns of α-synuclein, TNF-α, and IL-1β; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment
    Soham Mitra, Nilkanta Chakrabarti, Arindam Bhattacharyya · 2011 · Journal of Neuroinflammation